• Petar Šenjug, Tamara Nikuševa Martić, Marija Šenjug Perica, Maja Oroz, Matija Horaček, Kristina Gotovac Jerčić, Krešimir Galešić, and Danica Galešić Ljubanović.
• Tamara Nikuševa Martić, Department of Biology, Zagreb University School of Medicine, Šalata 3, 10000 Zagreb, Croatia, tamara.nikuseva.martic@mef.hr.
• Croat. Med. J. 2021 Jun 30; 62 (3): 204-214.

AimTo present the pathohistological and clinical characteristics of five Croatian families with Alport spectrum disorders caused by splice acceptor pathogenic variant c.193-2A>C in COL4A4 at the genomic position chr2:227985866.MethodsThe study enrolled five probands with kidney biopsy analysis and five family members. Mutation screening was performed with Illumina MiSeq platform. The pathogenic variant was confirmed with standard dye-terminator sequencing.ResultsThe only homozygous patient, aged two, had proteinuria and hematuria with preserved kidney function and no extrarenal manifestations. This patient had changes characteristic for Alport syndrome observed on electron microscopy of the kidney biopsy. In the heterozygous group, six patients had hematuria, four biopsied probands had proteinuria, and only one had moderately reduced kidney function. Heterozygous probands had variable kidney biopsy findings. Three patients had thin glomerular basement membrane nephropathy visible on electron microscopy and focal segmental glomerulosclerosis on light microscopy, two of them with focal lamellation on electron microscopy. One heterozygous patient had changes characteristic for Alport syndrome on electron microscopy without focal segmental glomerulosclerosis.ConclusionThe homozygous patient had hematuria and proteinuria with preserved kidney function. The heterozygous patients presented with reasonably mild clinical phenotype and variable pathohistological findings.

17 keywords...

hide…